Just received the paperwork from the Patent and Trademark Office that
all three biotechnology applications I filed last year have been
anointed and "Made Special" by the U.S. Army MEDCOM, and have now
entered an accelerated approval process as combat trauma medications
based my genetically mutated organelles.
These medications join the non-contact EKG I designed in 2006, which is
now beyond to proof of concept, and prototype stages and is in active
field testing by the U.S. Army. Still years from anything being approved
by the FDA, but the Army seems quite happy.
This is a proprietary notice only, and is not an offer to give, sell, or
provide and unapproved medical compounds or unapproved equipment prior
to formal approval by the FDA.
-jma
--
James M. Atkinson
President and Sr. Engineer
Granite Island Group
(978) 546-3803
jm..._at_tscm.com
http://www.tscm.com/
Received on Sat Mar 02 2024 - 00:57:27 CST